Search

Your search keyword '"Park, Seri"' showing total 238 results

Search Constraints

Start Over You searched for: Author "Park, Seri" Remove constraint Author: "Park, Seri"
238 results on '"Park, Seri"'

Search Results

6. Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer

9. Going Above and Beyond: Bridging the Gap Between Equitable Outcomes and Procedural Fairness in Health Policy Administration.

10. HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis

11. Exploring Relationship Between Driver’s Behavior and Cognitive Measures Observed by fNIRS in a Driving Simulator

12. Outcomes in Nonmetastatic Hormone Receptor–Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study

16. Social Equity and the Responsible Administrator: The Challenge of Equity in Public Policy Initiatives.

19. Assessment of the influence of [18F]florastamin isomer on pharmacokinetic properties for prostate cancer diagnosis: preclinical comparison of biodistribution

22. Corridor Deployment and Investigation of Anonymous Vehicle Tracking for Real-Time Traffic Performance Measurement

23. Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome

24. Evaluation of the adsorption performance and thermal treatment-associated regeneration of adsorbents for formaldehyde removal.

25. Anonymous Vehicle Tracking for Real-Time Freeway and Arterial Street Performance Measurement

26. Field Investigation of Advanced Vehicle Reidentification Techniques and Detector Technologies - Phase 2

28. Field Investigation of Advanced Vehicle Reidentification Techniques and Detector Technologies - Phase 1

34. Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

35. FigureS1 from Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer

36. Supplementary Tables 1-11 from Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer

37. Data from Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer

38. Abstract P5-03-14: Prevalence of germline BRCA mutations in unselected Korean patients with HER2-negative breast cancer: A Prospective cohort study

40. Abstract P3-05-36: Prognostic factors in non-metastatic hormone receptor-positive HER2-negative mucinous breast cancer: an international multicentre cohort study

42. Additional file 6 of Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer

47. Current state-of-practice: Transportation for patients with end stage renal disease

Catalog

Books, media, physical & digital resources